Home LiteratureArticle Details
PMID: 18971436 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Learning from molecular genetics: novel insights arising from the definition of genes for monogenic and type 2 diabetes.

Diabetes ·Vol. 57 ·No. 11 ·2008-11-00 ·Pages 2889-98

McCarthy MI, Hattersley AT

Abstract

暂无摘要

MeSH Terms
Animals Diabetes Mellitus, Type 2/genetics,pathology Genetic Heterogeneity Genetic Predisposition to Disease Hepatocyte Nuclear Factor 1-alpha/genetics Hepatocyte Nuclear Factor 1-beta/genetics Hepatocyte Nuclear Factor 4/genetics Humans Insulin-Secreting Cells/metabolism,pathology Models, Biological Molecular Biology/methods
Chemicals
Hepatocyte Nuclear Factor 1-alpha Hepatocyte Nuclear Factor 4 Hepatocyte Nuclear Factor 1-beta
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
McCarthy Mark I
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.
Hattersley Andrew T
References (92)
92 references, click to expand
  1. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease.
    Am J Hum Genet. 2001 Jan;68(1):219-24 PMID: 11085914
  2. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
    Diabetes. 2003 Feb;52(2):568-72 PMID: 12540637
  3. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1.
    Lancet. 2003 Jan 25;361(9354):301-7 PMID: 12559865
  4. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
    Diabetologia. 2003 Jan;46(1):3-19 PMID: 12637977
  5. Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice.
    J Biol Chem. 1998 Sep 18;273(38):24457-64 PMID: 9733737
  6. The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.
    J Clin Endocrinol Metab. 1999 Mar;84(3):1077-82 PMID: 10084598
  7. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease.
    Lancet. 1999 May 22;353(9166):1789-92 PMID: 10348008
  8. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta.
    Hum Mol Genet. 1999 Oct;8(11):2001-8 PMID: 10484768
  9. Type 2 diabetes: principles of pathogenesis and therapy.
    Lancet. 2005 Apr 9-15;365(9467):1333-46 PMID: 15823385
  10. What makes a good genetic association study?
    Lancet. 2005 Oct 8;366(9493):1315-23 PMID: 16214603
  11. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5.
    Diabetes. 2005 Nov;54(11):3126-32 PMID: 16249435
  12. Molecular genetics goes to the diabetes clinic.
    Clin Med. 2005 Sep-Oct;5(5):476-81 PMID: 16268330
  13. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction.
    Nat Genet. 2006 Jan;38(1):54-62 PMID: 16369531
  14. Does genetic testing really improve the prediction of future type 2 diabetes?
    PLoS Med. 2006 Feb;3(2):e114; author reply e127 PMID: 16492078
  15. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
    Nat Genet. 2006 Mar;38(3):320-3 PMID: 16415884
  16. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Hum Mol Genet. 2006 Jun 1;15(11):1793-800 PMID: 16613899
  17. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes.
    Endocrinology. 2006 Jun;147(6):2657-63 PMID: 16556760
  18. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    N Engl J Med. 2006 Aug 3;355(5):456-66 PMID: 16885549
  19. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    N Engl J Med. 2006 Aug 3;355(5):467-77 PMID: 16885550
  20. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene.
    Diabetologia. 2006 Sep;49(9):2210-3 PMID: 16816952
  21. p16INK4a induces an age-dependent decline in islet regenerative potential.
    Nature. 2006 Sep 28;443(7110):453-7 PMID: 16957737
  22. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development.
    Diabet Med. 2006 Dec;23(12):1301-6 PMID: 17116179
  23. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction.
    PLoS Med. 2006 Oct;3(10):e374 PMID: 17020404
  24. Human laminopathies: nuclei gone genetically awry.
    Nat Rev Genet. 2006 Dec;7(12):940-52 PMID: 17139325
  25. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses.
    Am J Hum Genet. 2006 Dec;79(6):991-1001 PMID: 17186458
  26. Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta.
    Nephrol Dial Transplant. 2004 Nov;19(11):2703-8 PMID: 15496559
  27. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance.
    Science. 1988 May 6;240(4853):787-90 PMID: 2834824
  28. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus.
    Nature. 1992 Mar 12;356(6365):162-4 PMID: 1545870
  29. Linkage of type 2 diabetes to the glucokinase gene.
    Lancet. 1992 May 30;339(8805):1307-10 PMID: 1349989
  30. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness.
    Nat Genet. 1992 Aug;1(5):368-71 PMID: 1284550
  31. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.
    J Clin Invest. 1994 Mar;93(3):1120-30 PMID: 8132752
  32. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome.
    Cell. 1996 Feb 23;84(4):575-85 PMID: 8598044
  33. Maternally inherited diabetes and deafness: a new diabetes subtype.
    Diabetologia. 1996 Apr;39(4):375-82 PMID: 8777986
  34. The future of genetic studies of complex human diseases.
    Science. 1996 Sep 13;273(5281):1516-7 PMID: 8801636
  35. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)
    Nature. 1996 Dec 5;384(6608):455-8 PMID: 8945470
  36. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
    Nature. 1996 Dec 5;384(6608):458-60 PMID: 8945471
  37. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY.
    Nat Genet. 1997 Dec;17(4):384-5 PMID: 9398836
  38. Mutations in the glucokinase gene of the fetus result in reduced birth weight.
    Nat Genet. 1998 Jul;19(3):268-70 PMID: 9662401
  39. Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction.
    Diabetes. 1998 Aug;47(8):1354-5 PMID: 9703339
  40. Genomewide association analysis of coronary artery disease.
    N Engl J Med. 2007 Aug 2;357(5):443-53 PMID: 17634449
  41. Genome-wide association studies provide new insights into type 2 diabetes aetiology.
    Nat Rev Genet. 2007 Sep;8(9):657-62 PMID: 17703236
  42. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function.
    PLoS One. 2007;2(9):e832 PMID: 17786204
  43. Insulin gene mutations as a cause of permanent neonatal diabetes.
    Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15040-4 PMID: 17855560
  44. Distinct roles of HNF1beta, HNF1alpha, and HNF4alpha in regulating pancreas development, beta-cell function and growth.
    Endocr Dev. 2007;12:33-45 PMID: 17923767
  45. The replication of beta cells in normal physiology, in disease and for therapy.
    Nat Clin Pract Endocrinol Metab. 2007 Nov;3(11):758-68 PMID: 17955017
  46. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
    Diabetes. 2007 Dec;56(12):3101-4 PMID: 17804762
  47. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
    Diabetes. 2007 Dec;56(12):3105-11 PMID: 17827400
  48. The emerging landscape of breast cancer susceptibility.
    Nat Genet. 2008 Jan;40(1):17-22 PMID: 18163131
  49. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study.
    Diabetes. 2008 Feb;57(2):514-7 PMID: 18039816
  50. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
    Diabetes Care. 2008 Feb;31(2):204-9 PMID: 18025408
  51. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.
    Nat Genet. 2008 Feb;40(2):217-24 PMID: 18176561
  52. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.
    Diabetologia. 2008 Apr;51(4):546-53 PMID: 18297260
  53. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes.
    Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):200-13 PMID: 18301398
  54. ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children.
    Pediatr Diabetes. 2006 Dec;7(6):352-60 PMID: 17212604
  55. A genome-wide association study identifies novel risk loci for type 2 diabetes.
    Nature. 2007 Feb 22;445(7130):881-5 PMID: 17293876
  56. Evaluation of common variants in the six known maturity-onset diabetes of the young (MODY) genes for association with type 2 diabetes.
    Diabetes. 2007 Mar;56(3):685-93 PMID: 17327436
  57. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
    Nat Genet. 2007 Apr;39(4):513-6 PMID: 17322881
  58. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene.
    PLoS Med. 2007 Apr;4(4):e118 PMID: 17407387
  59. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
    Science. 2007 May 11;316(5826):889-94 PMID: 17434869
  60. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes.
    Nat Genet. 2007 Jun;39(6):770-5 PMID: 17460697
  61. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.
    Science. 2007 Jun 1;316(5829):1331-6 PMID: 17463246
  62. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
    Science. 2007 Jun 1;316(5829):1341-5 PMID: 17463248
  63. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.
    Science. 2007 Jun 1;316(5829):1336-41 PMID: 17463249
  64. A common variant on chromosome 9p21 affects the risk of myocardial infarction.
    Science. 2007 Jun 8;316(5830):1491-3 PMID: 17478679
  65. A common allele on chromosome 9 associated with coronary heart disease.
    Science. 2007 Jun 8;316(5830):1488-91 PMID: 17478681
  66. Genetic prediction of future type 2 diabetes.
    PLoS Med. 2005 Nov 1;2(12):e345 PMID: 17570749
  67. Guilt beyond a reasonable doubt.
    Nat Genet. 2007 Jul;39(7):813-5 PMID: 17597768
  68. Copy-number variation and association studies of human disease.
    Nat Genet. 2007 Jul;39(7 Suppl):S37-42 PMID: 17597780
  69. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
    Diabetes. 2007 Aug;56(8):2178-82 PMID: 17519421
  70. Common variants in WFS1 confer risk of type 2 diabetes.
    Nat Genet. 2007 Aug;39(8):951-3 PMID: 17603484
  71. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
    Nat Genet. 2007 Aug;39(8):977-83 PMID: 17603485
  72. Growing evidence for diabetes susceptibility genes from genome scan data.
    Curr Diab Rep. 2003 Apr;3(2):159-67 PMID: 12728642
  73. Genetic cause of hyperglycaemia and response to treatment in diabetes.
    Lancet. 2003 Oct 18;362(9392):1275-81 PMID: 14575972
  74. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas.
    Diabetes Care. 2003 Nov;26(11):3191-2 PMID: 14578267
  75. Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas.
    Hum Mol Genet. 2003 Dec 15;12(24):3307-14 PMID: 14570708
  76. Revisiting the clinical validity of multiplex genetic testing in complex diseases.
    Am J Hum Genet. 2004 Mar;74(3):585-8; author reply 588-9 PMID: 14973786
  77. Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification.
    Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R33-41 PMID: 14722160
  78. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations.
    Ann Intern Med. 2004 Apr 6;140(7):510-7 PMID: 15068978
  79. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
    Diabetes Care. 2004 May;27(5):1102-7 PMID: 15111528
  80. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
    N Engl J Med. 2004 Apr 29;350(18):1838-49 PMID: 15115830
  81. Transcriptional networks controlling pancreatic development and beta cell function.
    Diabetologia. 2004 Apr;47(4):597-613 PMID: 15298336
  82. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
    Diabetes. 2004 Oct;53(10):2713-8 PMID: 15448106
  83. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation.
    Diabet Med. 2008 Apr;25(4):383-99 PMID: 18294221
  84. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
    Nat Genet. 2008 May;40(5):638-45 PMID: 18372903
  85. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations.
    Diabetes. 2008 Jun;57(6):1659-63 PMID: 18268044
  86. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
    Nature. 1999 Dec 23-30;402(6764):880-3 PMID: 10622252
  87. Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta.
    Kidney Int. 2000 Mar;57(3):898-907 PMID: 10720943
  88. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes.
    Genome Res. 2000 May;10(5):652-8 PMID: 10810087
  89. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.
    Nat Genet. 2000 Aug;25(4):406-9 PMID: 10932183
  90. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.
    Nat Genet. 2000 Sep;26(1):76-80 PMID: 10973253
  91. MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of "neonatal diabetes"?
    Diabetologia. 2000 Oct;43(10):1331-2 PMID: 11079754
  92. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy.
    Nat Genet. 2001 Jan;27(1):18-20 PMID: 11137992
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
1939-327X
DOI
10.2337/db08-0343
Published
2008-11-00
Pages
2889-98
Language
English
Region
United States
NLM ID
0372763
PMCID
PMC2570381
Subset
IM
Grants
Wellcome Trust · 067463 · United Kingdom
Wellcome Trust · 076113 · United Kingdom
Wellcome Trust · 083948 · United Kingdom
Medical Research Council · G0601261 · United Kingdom
External Links
PubMed source DOI: 10.2337/db08-0343 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2